Patent · US Active

Process for preparation of dapagliflozin

US10556877B2 · kind B2 · utility

0Cited by
3References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 4, 2016
Grant dateFeb 11, 2020
Priority date
Expiry dateMay 4, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H7/04
  • WIPO fieldChemical engineering
  • WIPO sectorChemistry

Abstract

The present invention relates to a process for the preparation of amorphous dapagliflozin. The present invention relates to 2,3-butanediol solvate of dapagliflozin and process for its preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.